Early treatment for early stage multiple myeloma may slow the disease...
Multiple myeloma (MM) is cancer of the bone marrow. It causes bone destruction that leads to pain, spinal cord compression and fractures.In early stages, most people do not show any symptoms of MM. It...
View ArticleHigh-dose chemotherapy plus single vs tandem autologous transplantation as...
Multiple myeloma is a cancer of antibody-producing cells in the bone marrow. It causes bone destruction and patients are usually at a higher risk for infections and renal damage. Autologous stem cell...
View ArticleMycophenolate mofetil versus methotrexate for prevention of graft-versus-host...
Background Allogeneic hematopoietic stem cell transplantation is a procedure in which a portion of a healthy donor's stem cells (cells that can develop into various types of blood cells) or bone...
View ArticleAdding plerixafor to G-CSF for stem cell mobilisation for autologous...
Review question We reviewed the existing literature regarding the efficacy and safety of additional plerixafor to granulocyte colony-stimulating factors (G-CSF) versus G-CSF only for stem cell...
View ArticleThe role of bortezomib treatment for patients with multiple myeloma
Background Multiple myeloma is a type of blood cancer, affecting plasma cells inside the bone marrow. Bortezomib is a type of treatment for myeloma called a proteasome inhibitor. Proteasomes are...
View ArticleBisphosphonates in multiple myeloma
Review question: What is the effect of bisphosphonates if added to the existing treatments for multiple myeloma? Background: Multiple myeloma (also known as myeloma or plasma cell myeloma) is a B-cell...
View ArticleEarly treatment for early stage multiple myeloma may slow the disease...
Multiple myeloma (MM) is cancer of the bone marrow. It causes bone destruction that leads to pain, spinal cord compression and fractures.In early stages, most people do not show any symptoms of MM. It...
View ArticleHigh-dose chemotherapy plus single vs tandem autologous transplantation as...
Multiple myeloma is a cancer of antibody-producing cells in the bone marrow. It causes bone destruction and patients are usually at a higher risk for infections and renal damage. Autologous stem cell...
View ArticleMycophenolate mofetil versus methotrexate for prevention of graft-versus-host...
Background Allogeneic hematopoietic stem cell transplantation is a procedure in which a portion of a healthy donor's stem cells (cells that can develop into various types of blood cells) or bone marrow...
View ArticleAdding plerixafor to G-CSF for stem cell mobilisation for autologous...
Review question We reviewed the existing literature regarding the efficacy and safety of additional plerixafor to granulocyte colony-stimulating factors (G-CSF) versus G-CSF only for stem cell...
View ArticleThe role of bortezomib treatment for patients with multiple myeloma
Background Multiple myeloma is a type of blood cancer, affecting plasma cells inside the bone marrow. Bortezomib is a type of treatment for myeloma called a proteasome inhibitor. Proteasomes are...
View ArticleBisphosphonates in multiple myeloma
Review question: What is the effect of bisphosphonates if added to the existing treatments for multiple myeloma? Background: Multiple myeloma (also known as myeloma or plasma cell myeloma) is a B-cell...
View ArticleMultiple drug combinations of bortezomib, lenalidomide and thalidomide for...
Multiple drug combinations of bortezomib, lenalidomide and thalidomide for initial treatment of adults with transplant-ineligible multiple myeloma Background Multiple myeloma is a type of blood...
View Article
